Home Featured Page 129

Featured

Latest

Areyto Boriken – Ethnobotanical Adventure

The Ram Dass Institute of Psychedelic Studies with The Dying Inaugural Event on Maui

International Conference on Assisted Dying and Other End of Life Care (ICEL5)

Michael Ryoshin Sapiro, PsyD – Truth Medicine, Psychedelics, and Living Your Truth

What the Cancer Community Actually Needs from Psychedelic Care

Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming...

Many Trips, Diminishing Returns: Cross-Tolerance Between LSD and DOI

PT375 – Microdosing & Citizen Science: Introducing the World’s First Take-Home...

Small Pharma to Participate in November Investor and Healthcare Conferences

Silo Pharma Initiates Study of Novel Joint Homing Peptide in Human...

Tryp Therapeutics Announces Poster Presentations on the Reduction of Chronic Pain...

Psychedelics Weekly – Bipartisan Political Movement & Psychedelics and Pain

How To Stop A Psychedelic Trip: The Promise of Ketanserin

Numinus to Participate in a Water Tower Research Fireside Chat on...

atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical...

1...128129130...303 Page 129 of 303

Areyto Boriken – Ethnobotanical Adventure

The Ram Dass Institute of Psychedelic Studies with The Dying Inaugural...

International Conference on Assisted Dying and Other End of Life Care...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Areyto Boriken – Ethnobotanical Adventure

The Ram Dass Institute of Psychedelic Studies with The Dying Inaugural Event on Maui

International Conference on Assisted Dying and Other End of Life Care (ICEL5)

Michael Ryoshin Sapiro, PsyD – Truth Medicine, Psychedelics, and Living Your Truth

What the Cancer Community Actually Needs from Psychedelic Care

Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming...

Many Trips, Diminishing Returns: Cross-Tolerance Between LSD and DOI

PT375 – Microdosing & Citizen Science: Introducing the World’s First Take-Home...

Small Pharma to Participate in November Investor and Healthcare Conferences

Silo Pharma Initiates Study of Novel Joint Homing Peptide in Human...

Tryp Therapeutics Announces Poster Presentations on the Reduction of Chronic Pain...

Psychedelics Weekly – Bipartisan Political Movement & Psychedelics and Pain

How To Stop A Psychedelic Trip: The Promise of Ketanserin

Numinus to Participate in a Water Tower Research Fireside Chat on...

atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical...

EDITOR PICKS

Areyto Boriken – Ethnobotanical Adventure

The Ram Dass Institute of Psychedelic Studies with The Dying Inaugural...

International Conference on Assisted Dying and Other End of Life Care...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY